CovalX will be attending The 21st Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, which will congregate over 1,300 drug discovery professionals in Sheraton, Boston, MA, on September 25-28, 2023
This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules. CovalX team will be there to aid the scientific community to succeed in their development of biopharmaceuticals.
Please let us know if you are available to connect during the conference at Booth #106. If you are planning to attend this event, CovalX scientific team will be there for brief information on our current and new services. CovalX is the leader in protein interaction analysis, protein aggregation analysis and epitope mapping by mass spectrometry. Contact us at email@example.com, +1(617) 297 2263, or CovalX.com